Related Articles
Safety and efficacy of panitumumab therapy after metastatic colorectal cancer progression with cetuximab: Experience at a single Japanese institution
EphA2 receptor activation with ephrin-A1 ligand restores cetuximab efficacy in NRAS-mutant colorectal cancer cells
Cetuximab retreatment in patients with metastatic colorectal cancer who exhibited a clinical benefit in response to prior cetuximab: A retrospective study
Cetuximab treatment for metastatic colorectal cancer with KRAS p.G13D mutations improves progression-free survival
KRAS mutations in Slovene patients with colorectal cancer: frequency, distribution and correlation with the response to treatment